Three-year Clinical Performance of a Universal Adhesive in Non-Carious Cervical Lesions.

PURPOSE: The aim of this randomized controlled clinical trial was to evaluate the 3-year clinical performance of a universal adhesive (Clearfil Universal Bond Quick (CUBQ); Kuraray Noritake) when restoring non-carious cervical lesions (NCCLs) using two different application modes (etch-and-rinse vs self-etch with prior selective enamel etching). MATERIALS AND METHODS: Fifty-one patients participated in this study. A total of 251 NCCLs (n = 251) were assigned to two groups: 1) CUBQ applied in etch-and-rinse mode (n = 122; CUBQ-ER) and 2) CUBQ applied in self-etch mode with prior selective etching of enamel with phosphoric acid (n = 129; CUPQ-SEE). The same resin composite, Clearfil Majesty ES-2 (Kuraray Noritake), was used for all restorations. The restorations were evaluated at baseline, 1 and 3 years using FDI criteria: marginal staining, fracture and retention, marginal adaptation, post-operative sensitivity and recurrence of caries. Statistical analysis was performed using a logistic regression model with generalized estimating equations (2-way GEE model). RESULTS: The patient recall rate at 3 years was 90%. After 3 years, both groups presented an increase in the percentage of small but still clinically acceptable marginal defects (CUBQ-ER: 67%, CUBQ-SEE: 63.2%) and marginal staining (CUBQ-ER: 32.6%, CUBQ-SEE: 31.7%). The overall success rate was 82.6% and 83.8% for CUBQ-ER and CUBQ-SEE, respectively. In total, 38 restorations (19 CUBQ-ER, 19 CUBQ-SEE) failed because of loss of retention, fracture, severe marginal defect and/or marginal discoloration. A retention rate of 87.2% and 86.3% was recorded for CUBQ-ER and CUBQ-SEE, respectively. No significant difference was observed between the two bonding-mode groups for any of the evaluated parameters. CONCLUSION: After 3 years of clinical service, Clearfil Universal Bond Quick performed similarly in etch-and-rinse and self-etch modes with prior selective enamel etching.

Community pharmacists' attitude toward depression: a pilot study.

BACKGROUND: Pharmacists' expanding roles may be witness to greater involvement in mental illnesses, of which depression is the disorder with the highest prevalence. Little, however, is known on pharmacists' attitude toward depression, although it may affect pharmacists' service provision and lead to stigmatization of patients. OBJECTIVE: This study is intended as a pilot to explore community pharmacists' attitude toward depression, components in the attitude, and factors related to it. METHODS: A random sample of 200 community pharmacists in Belgium was surveyed on the attitude toward depression. To measure this attitude, we used a modified version (adapted to the specific context of pharmacists) of the Depression Attitude Questionnaire (DAQ), which covers several aspects of the attitude toward depression. RESULTS: Pharmacists' attitude toward depression was generally favorable, but some opinions about depression treatment were not. This attitude could be summarized by 4 components (the attitude toward the treatment of depression, toward the course of depression, toward pharmacists' role in depression care, and toward patients with depression), although several limitations in the component solution were observed. Older pharmacists and those with a more pessimistic attitude toward the course of depression endorsed a more negative attitude toward patients with depression. CONCLUSIONS: The generally favorable attitude of community pharmacists toward depression is promising with regard to their role in depression care. Training programs, preferably including patients with depression themselves, are needed to further improve unfavorable attitudes. Further work is needed to refine the pharmacists' adapted DAQ.

Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers.

OBJECTIVE: Pharmacists may be well placed to take up a role in depression care, complementing the role of general practitioners. However, depression care is a relatively new role for pharmacists, and little is known of their attitudes, current practices, and barriers toward it. METHODS: A random sample of 200 community pharmacists in Belgium was surveyed about the care of patients with depression in comparison with patients with other, physical conditions. RESULTS: The 69 pharmacists who responded to the survey generally endorsed a very positive attitude toward their potential role in depression care. This willingness was, however, not reflected in current practice, and fulfilling this role appeared to be more difficult with patients with depression in comparison with patients with other, physical conditions. A lack of training in mental health issues was the most important barrier reported. Cooperation with general practitioners in depression care was desired, but the current level of cooperation was rather low. CONCLUSIONS: For pharmacists to effectively take up depression care, perceived barriers need to be addressed through specific training programs and increased cooperation with general practitioners.